Bicycle Therapeutics Plc ADR (BCYC)
13.18 -0.38 (-2.80%) 13:58 ET [NASDAQ]
13.04 x 3 13.25 x 7
Realtime by (Cboe BZX)
13.04 x 3 13.25 x 7
Realtime 13.56 unch (unch) 09:29 ET
for Wed, Jan 22nd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 2,676 | 9,361 | 19,530 | 5,331 | 5,352 |
Gross Profit | 2,676 | 9,361 | 19,530 | 5,331 | 5,352 |
Operating Expenses | 66,522 | 56,008 | 51,246 | 59,566 | 56,149 |
Operating Income | -63,846 | -46,647 | -31,716 | -54,235 | -50,797 |
Interest Expense | 33 | 824 | 821 | 820 | 814 |
Other Income | 9,629 | 7,774 | 5,624 | 6,276 | 3,985 |
Pre-tax Income | -54,250 | -39,697 | -26,913 | -48,779 | -47,626 |
Income Tax | -3,448 | 115 | -350 | 320 | 2,272 |
Net Income Continuous | -50,802 | -39,812 | -26,563 | -49,099 | -49,898 |
Net Income | $-50,802 | $-39,812 | $-26,563 | $-49,099 | $-49,898 |
EPS Basic Total Ops | -0.74 | -0.77 | -0.62 | -1.11 | -1.26 |
EPS Basic Continuous Ops | -0.74 | -0.77 | -0.62 | -1.10 | -1.26 |
EPS Diluted Total Ops | -0.74 | -0.77 | -0.62 | -1.11 | -1.26 |
EPS Diluted Continuous Ops | -0.74 | -0.77 | -0.62 | -1.10 | -1.26 |
EPS Diluted Before Non-Recurring Items | -0.74 | -0.77 | -0.62 | -1.16 | -1.26 |
EBITDA(a) | $-61,674 | $-45,007 | $-30,058 | $-52,581 | $-49,107 |